Allarity Therapeutics, Inc. (ALLR): Nasdaq/NYSE listing notice — Allarity receives Nasdaq delisting notice over independent director/audit committee non-compliance

Allarity Therapeutics, Inc.

Nasdaq notified Allarity on Feb 8, 2023 that it fails Listing Rules 5605(b)(1)(A) and 5605(c)(4) after director Soren G. Jensen resigned from board and audit committee, effective Feb 4, 2023.
No immediate effect on listing; common stock continues trading under ALLR on Nasdaq Global Market.
Cure period: must comply by earlier of next annual shareholders' meeting or Feb 4, 2024; if annual meeting before Aug 3, 2023, compliance due by Aug 3, 2023.
Company is seeking a new independent director who qualifies for audit committee membership to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Allarity Therapeutics, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(b)(1)(A), 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(b)(1)(A), 5605(c)(4)

Exact text from the filing

February 8, 2023, Allarity Therapeutics, Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the resignation of Soren G. Jensen from the Company’s board and audit committee, effective on February 4, 2023, the Company no longer complies with Nasdaq’s independent director and audit committee requirements as set forth in Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4) which requires a majority of the board of directors to be comprised of independent directors and an audit committee of at least three independent dire

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Allarity Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-010353

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.